Ireland· IE-PA-PA0584/005/001
CUROSURF 120 mg/vial Endotracheopulmonary instillation, suspension
A natürliche phospholipide product containing porcine lung surfactant, registered in Ireland by Chiesi Farmaceutici S.p.A.. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Natürliche phospholipide is registered in 11 of 19 countries.
Countries holding a registration under ATC R07AA02 (natürliche phospholipide), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 7 of them publish a price we can compare per daily dose
Natürliche phospholipide · ATC R07AA02
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Porcine lung surfactant
- Manufacturer
- Chiesi Farmaceutici S.p.A.
- Country
- Ireland (IE)
- ATC code
- R07AA02
- ATC class
- Natürliche Phospholipide
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA0584/005/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Natürliche phospholipide in 9 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCurosurfOrifarm Oy
- SwedenCurosurf 80 mg/ml Instillationsvätska för luftvägarna, suspensionChiesi Farmaceutici S.p.A.
- FranceCUROSURF 120 mg/1,5 ml, suspension pour instillation endotrachéobronchiqueCHIESI
- PolandCurosurfDelfarma Sp. z o.o.
- United KingdomCurosurf 120mg/1.5ml endotracheopulmonary suspension vialsChiesi Ltd
- United StatesCurosurfChiesi USA, Inc.
- GermanyCurosurfChiesi Gmbh
- NorwayCurosurfChiesi Farmaceutici S.p.a.
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Curosurf
- Belgium · Curosurf
- Bulgaria · Куросърф
- Cyprus · Curosurf
- Czechia · Curosurf
- Denmark · Curosurf
- Estonia · Curosurf
- Spain · Curosurf
- Finland · Curosurf
- France · Curosurf
- United Kingdom (Northern Ireland) · Curosurf
- Greece · Curosurf
- Croatia · Curosurf
- Hungary · Curosurf
- Iceland · Curosurf
- Italy · Curosurf
- Lithuania · Curosurf
- Luxembourg · Curosurf
- Latvia · Curosurf
- Malta · Curosurf
- Netherlands · Curosurf
- Norway · Curosurf
- Poland · Curosurf
- Portugal · Curosurf
- Romania · Curosurf
- Sweden · Curosurf
- Slovenia · Curosurf
- Slovakia · Curosurf
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e54b2c3d-fafe-4af5-9044-1a57dfd34430 GET /v1/drugs/e54b2c3d-fafe-4af5-9044-1a57dfd34430?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Endotracheopulmonary instillation, suspension",
"routes": [
"Endotracheopulmonary use"
],
"source": "hpra",
"atc_all": [
"R07AA",
"R07AA02"
],
"strength": null,
"pa_number": "PA0584/005/001",
"substances": [
"Porcine lung surfactant"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Marketed",
"authorised_at": "08/09/1994",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about natürliche phospholipide.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.